News & Resources

Latest News

Learn more

Company News

BioDuro-Sundia Bengbu Site Passes Pre-Approval Inspection by China’s Medical Products Administration with Zero Observations

IRVINE, CALIF., November 21, 2024 – BioDuro-Sundia, a leading global contract research, development, and manufacturing organization (CRDMO), today announced that its site in Bengbu, China, achieved a
November 21, 2024

Fully Integrated CRDMO

One Stop Shop to Accelerate Your Innovations

Drug Substance

Scale Up g → kg

API, RSMs & Intermediates

IND Filing (FDA, NMPA and others)

Learn more

Drug Product

Solubility Enhancement

Solid Oral Dosage Forms

Clinical & Commercial

Learn more

Platforms

Integrated Platforms and Solutions

Learn more

Fully automatic, flexible and customized solutions

Discover drugs faster with our comprehensive
in vitro evaluation platform

Bioavailability enhancement

Integrated services under one roof: synthetic chemistry, biology, DMPK, more.

Our one stop shop platform seamlessly
integrates preclinical research services

Tailored engine for small molecular drug discovery
Unlock exponential possibilities screening billions of small molecules

Advanced preclinical models for NASH
Clinical relevance, shortened timelines

Delayed, sustained, and custom release

Featured Resources

New Resources

Learn more